ArticleMediators of inflammation2026
Zengwei Chengqi Decoction Reduces Inflammation in Acute Intestinal Obstruction.
Article in Mediators of inflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Zengwei Chengqi Decoction Reduces Inflammation in Acute Intestinal Obstruction.Mediators of inflammation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectiveThis study investigates the therapeutic effects of Zengwei Chengqi Decoction (ZW) on acute intestinal obstruction (AIO), focusing on its ability to alleviate inflammation and reduce associated tissue damage. Network pharmacology and experimental animal models were used to explore the mechanisms of action.
methodsUsing network pharmacology, we identified 228 active compounds in ZW and 420 corresponding targets linked to inflammation. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were used to identify the biological pathways influenced by ZW. In vivo, an SD rat model of AIO was induced, and the therapeutic effects of ZW were assessed by histological examination of tissue damage and serum cytokine levels.
resultsTreatment with ZW significantly mitigated tissue damage in AIO rats. Additionally, serum levels of pro-inflammatory cytokines, including IL-1β, IL-6, and TNF-α, were substantially reduced in the ZW-treated group compared to the control group (p < 0.01).
conclusionZW shows strong potential for modulating inflammation in AIO, as evidenced by reduced cytokine levels and improved tissue integrity. These findings provide valuable insights into the mechanisms underlying its therapeutic effects, positioning ZW as a promising treatment for AIO.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.